Endomorphin-2 and endomorphin-1 promote the extracellular amount of accumbal dopamine via nonopioid and mu-opioid receptors, respectively

Neuropsychopharmacology

Volumn 31, Issue 2, 2006, Pages 375-383

  Okutsu, Hiroko ^a,b   Watanabe, Shu ^b   Takahashi, Ichiro ^b   Aono, Yuri ^b   Saigusa, Tadashi ^b,d   Koshikawa, Noriaki ^b   Cools, Alexander R ^c  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d ASTELLAS PHARMA INC   (Japan)

Author keywords

Dopamine release; Endomorphin 1; Endomorphin 2; Nucleus accumbens; Opioid; Rat

Indexed keywords

DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DOPAMINE; ENDOMORPHIN 1; ENDOMORPHIN 2; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALOXONAZINE; TETRODOTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOSE RESPONSE; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ANALGESICS, OPIOID; ANESTHETICS, LOCAL; ANIMALS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; DIALYSIS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXTRACELLULAR SPACE; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NUCLEUS ACCUMBENS; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SOMATOSTATIN; TETRODOTOXIN; WAKEFULNESS;

EID: 30944437421     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300804     Document Type: Article

References (38)

1. Benveniste H, Hansen AJ, Ottosen NS (1989). Determination of brain interstitial concentrations by microdialysis. J Neurochem 52: 1741-1750.
2. Champion HC, Zadina JE, Kastin AJ, Hackler L, Ge LJ, Kadowitz PJ (1997). Endomorphin 1 and 2, endogenous ligands for the mu-opioid receptor, decrease cardiac output, and total peripheral resistance in the rat. Peptides 18: 1393-1397.
3. Chapman V, Diaz A, Dickenson AH (1997). Distinct inhibitory effects of spinal endomorphin-1 and endomorphin-2 on evoked dorsal horn neuronal responses in the rat. Br J Pharmacol 122: 1537-1539.
4. + conductance of rat locus ceruleus neurons. Mol Pharmacol 50: 650-655.
5. Czapla MA, Champion HC, Zadina JE, Kastin AJ, Hackler L, Ge LJ et al (1998). Endomorphin 1 and 2, endogenous mu-opioid agonists, decrease systemic arterial pressure in the rat. Life Sci 62: PL175-179.
6. 3H-dopamine uptake in rat striatum and nucleus accumbens. Neuropharmacology 33: 221-226.
7. Feigenbaum JJ, Howard SG (1997). Effects of naloxone on amphetamine induced striatal dopamine release in vivo: a microdialysis study. Life Sci 60: 1659-1668.
8. Fischer A, Undem BJ (1999). Naloxone blocks endomorphin-1 but not endomorphin-2 induced inhibition of tachykinergic contractions of guinea-pig isolated bronchus. Br J Pharmacol 127: 605-608.
9. Fusa K, Saigusa T, Koshikawa N, Cools AR (2002). Tyrosine-induced release of dopamine is under inhibitory control of presynaptic dopamine D2 and, probably, D3 receptors in the dorsal striatum, but not in the nucleus accumbens. Eur J Pharmacol 448: 143-150.
10. Fusa K, Takahashi I, Watanabe S, Aono Y, Ikeda H, Saigusa T et al (2005). The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals. Neuroscience 130: 745-755.
11. Goldberg IE, Rossi GC, Letchworth SR, Mathis JP, Ryan-Moro J, Leventhal L et al (1998). Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J Pharmacol Exp Ther 286: 1007-1013.
12. Hackler L, Zadina JE, Ge L-J, Kastin AJ (1997). Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex. Peptides 18: 1635-1639.
13. Lindefors N, Amberg G, Ungerstedt U (1989). Intracerebral microdialysis: I. Experimental studies of diffusion kinetics. J Pharmacol Methods 22: 141-156.
14. Martin G, Nie Z, Siggins GR (1997). Mu-opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons. J Neurosci 17: 11-22.
15. Martin-Schild S, Gerall AA, Kastin AJ, Zadina JE (1999). Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J Comp Neurol 405: 450-471.
16. Mehta A, Bot G, Reisine T, Chesselet MF (2001). Endomorphin-1: induction of motor behavior and lack of receptor desensitization. J Neurosci 21: 4436-4442.
17. Murai T, Koshikawa N, Kanayama T, Takada K, Tomiyama K, Kobayashi M (1994). Opposite effects of midazolam and beta-carboline-3-carboxylate ethyl ester on the release of dopamine from rat nucleus accumbens measured by in vivo microdialysis. Eur J Pharmacol 261: 65-71.
18. Ohsawa M, Mizoguchi H, Narita M, Nagase H, Kampine JP, Tseng LF (2001). Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther 298: 592-597.
19. Pasternak GW, Wood PJ (1986). Multiple mu opiate receptors. Life Sci 38: 1889-1898.
20. Paxinos G, Watson C (1998). The Rat Brain in Sterotaxic Coordinates, 4th edn. Academic Press: New York.
21. Piepponen TP, Ahtee L (1995). Effects of selective opioid receptor antagonists on morphine-induced changes in striatal and limbic dopamine metabolism. Pharmacol Toxicol 77: 204-208.
22. Saigusa T, Fusa K, Okutsu H, Koshikawa N (2001). Monitoring of extracellular dopamine levels in the dorsal striatum and the nucleus accumbens with 5-minute on-line microdialysis in freely moving rats. J Oral Sci 43: 129-134.
23. Saigusa T, Takada K, Baker SC, Kumar R, Stephenson JD (1997). Dopamine efflux in the rat nucleus accumbens evoked by dopamine receptor stimulation in the entorhinal cortex is modulated by oestradiol and progesterone. Synapse 25: 37-43.
24. Saigusa T, Tuinstra T, Koshikawa N, Cools AR (1999). High and low responders to novelty: effects of a catecholamine synthesis inhibitor on novelty-induced changes in behavior and release of accumbal dopamine. Neuroscience 88: 1153-1163.
25. Sakurada S, Hayashi T, Yuhki M, Fujimura T, Murayama K, Yonezawa A et al (2002). Differential antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by naloxonazine and 3-methylnaltrexone. Peptides 23: 895-901.
26. Sakurada S, Hayashi T, Yuhki M, Fujimura T, Murayama K, Yonezawa A et al (2000). Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone. Brain Res 881: 1-8.
27. Sakurada S, Hayashi T, Yuhki M, Orito T, Zadina JE, Kastin AJ et al (2001). Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. Eur J Pharmacol 427: 203-210.
28. Sakurada S, Zadina JE, Kastin AJ, Katsuyama S, Fujimura T, Murayama K et al (1999). Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception. Eur J Pharmacol 372: 25-30.
29. Schreff M, Schulz S, Wiborny D, Hollt V (1998). Immunofluorescent identification of endomorphin-2-containing nerve fibers and terminals in the rat brain and spinal cord. Neuroreport 9: 1031-1034.
30. Stone LS, Fairbanks CA, Laughlin TM, Nguyen HO, Bushy TM, Wessendorf MW et al (1997). Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2. Neuroreport 8: 3131-3135.
31. Takada K, Murai T, Kanayama T, Koshikawa N (1993). Effects of midazolam and flunitrazepam on the release of dopamine from rat striatum measured by in vivo microdialysis. Br J Anaesth 70: 181-185.
32. Tomiyama K, Koshikawa N, Funada K, Oka K, Kobayashi M (1995). In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum. J Neurochem 65: 2790-2795.
33. Tomiyama K, Noguchi M, Koshikawa N, Kobayashi M (1993). YM-09151-2 but not 1-sulpiride induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism. J Neurochem 60: 1690-1695.
34. Tseng LF, Narita M, Suganuma C, Mizoguchi H, Ohsawa M, Nagase H et al (2000). Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther 292: 576-583.
35. Wang XM, Zhang KM, Long LO, Flores CA, Mokha SS (2000). Endomorphin-1 and endomorphin-2 modulate responses of trigeminal neurons evoked by N-methyl-D-aspartic acid and somatosensory stimuli. J Neurophysiol 83: 3570-3574.
36. Wollemann M, Benyhe S (2004). Non-opioid actions of opioid peptides. Life Sci 75: 257-270.
37. Yoshida Y, Koide S, Hirose N, Takada K, Tomiyama K, Koshikawa N et al (1999). Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors. Neuroscience 92: 1357-1365.
38. Zadina JE, Hackler L, Ge L-J, Kastin AJ (1997). A potent and selective endogenous agonist for the mu-opiate receptor. Nature 386: 499-502.